Cantitate/Preț
Produs

Sjogren's Syndrome: Novel Insights in Pathogenic, Clinical and Therapeutic Aspects

Editat de Alessia Alunno, Elena Bartoloni, Roberto Gerli
en Limba Engleză Hardback – 22 iun 2016
Sjogren's Syndrome: Novel Insights in Pathogenic, Clinical and Therapeutic Aspects provides the reader with an overview of current knowledge about Sjogren's Syndrome. The book summarizes the huge amount of literature concerning related advances in genetic background, pathogenesis, clinical picture, and therapeutic approaches. It integrates basic immunology concepts, clinical aspects, and pharmacological issues.
Scientific progress has allowed us to unmask novel pathogenic mechanisms, to perform genome wide studies, and to identify clinical and serological features associated with different disease subsets and, eventually, different disease prognoses. In addition, the increasing knowledge about SS pathogenesis provides the rationale to employ targeted therapies in SS as has already occurred in rheumatoid arthritis and systemic lupus erythematosus.


  • Discusses heterogeneity of topics and audience, from basic immunology to clinical aspects and therapeutics
  • Provides novel lines of investigation and supports the management of patients requiring novel therapeutic approaches
  • Presents a deeper knowledge on SS clinical management as well as on immunological aspects possibly leading to new lines of investigation
  • Offers a bridge between the clinician and the scientist, and vice versa
  • Provides the reader with most recent and relevant updates due to the novelty of topics
Citește tot Restrânge

Preț: 42770 lei

Preț vechi: 56713 lei
-25% Nou

Puncte Express: 642

Preț estimativ în valută:
8188 8425$ 6902£

Carte tipărită la comandă

Livrare economică 22 februarie-08 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128036044
ISBN-10: 0128036044
Pagini: 344
Dimensiuni: 152 x 229 x 23 mm
Greutate: 0.73 kg
Editura: ELSEVIER SCIENCE

Cuprins

-Genetics and epigenetics in SS
-Environmental factors in SS development
-SS classification criteria in 2014: shall we improve them?
-Glandular epithelium: innocent bystander or leading actor?
-T cells in SS pathogenesis: more than just Th1 and Th2
-B cells in SS pathogenesis: the good and the evil
-Other immune cells in SS pathogenesis
-Autoantibodies in SS: SSA, SSB and beyond
-The kaleidoscope of clinical picture in SS
-Extra-glandular manifestations in SS
-Outcome measures in SS
-SS associated lymphoma
-Novel therapeutic strategies in SS: B-cell targeting
-Novel therapeutic strategies in SS: T-cell targeting